MAPT and Alzheimer disease: Since synaptic malfunction and loss correlates strongly with cognitive deficits in AD patients (Wang and Mandelkow, 2016; Müller et al., 2017), a better understanding of the pathophysiology of soluble Aβ and hyperphosphorylated Tau is imperative.